Knockdown of DNA polymerase ζ relieved the chemoresistance of glioma via inhibiting the PI3K/AKT signaling pathway

References

• Alahverdi A, Arefian E, Soleimani M, et al. Involvement of EGFR, ERK-1,2 and AKT-1,2 activity on human glioma cell growth. Asian Pac J Cancer Prev. 2020;21:3469–3475.
   PubMedGoogle Scholar
• Xu W, Hu J, Liu W, et al. Remimazolan inhibits glioma cell growth and induces apoptosis through down-regulation of NF-kappaB pathway. IUBMB Life. 2020;73(2):341–348.
   Web of Science ®Google Scholar
• Sun J, Ma Q, Shu C, et al. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression. Int J Oncol. 2020;58(1):45–56. .
   Web of Science ®Google Scholar
• Ruiz-Garcia H, Alvarado-Estrada K, Krishnan S, et al. Nanoparticles for stem cell therapy bioengineering in glioma. Front Bioeng Biotechnol. 2020;8:558375.
   PubMed Web of Science ®Google Scholar
• Bukhari SS, Shamim MS. Can awake glioma surgery be the new standard of care in developing countries? Surg Neurol Int. 2020;11:434.
   PubMedGoogle Scholar
• O’Neal CM, Stephens TM, Briggs RG, et al. Navigated transcranial magnetic stimulation following awake craniotomy for resection of glioma: description of two cases. Surg Neurol Int. 2020;11:433.
   PubMedGoogle Scholar
• Zhang Z, Jin Z, Yang X, et al. Pre-operative neurocognitive function was more susceptible to decline in isocitrate dehydrogenase wild-type subgroups of lower-grade glioma patients. Front Neurol. 2020;11:591615.
   PubMed Web of Science ®Google Scholar
• Gallina I, Hendriks IA, Hoffmann S, et al. The ubiquitin ligase RFWD3 is required for translesion DNA synthesis. Mol Cell. 2021;81(3):442–458.e9.
   PubMed Web of Science ®Google Scholar
• Cano-Linares MI, Yanez-Vilches A, Garcia-Rodriguez N, et al. Non-recombinogenic roles for Rad52 in translesion synthesis during DNA damage tolerance. EMBO Rep. 2020;22(1):e50410.
   Google Scholar
• Jung H, Hawkins M, Lee S. Structural insights into the bypass of the major deaminated purines by translesion synthesis DNA polymerase. Biochem J. 2020;477(24):4797–4810.
   PubMed Web of Science ®Google Scholar
• Shilkin ES, Boldinova EO, Stolyarenko AD, et al. Translesion DNA synthesis and reinitiation of DNA synthesis in chemotherapy resistance.Biochemistry(Mosc). 2020;85(8):869–882.
   Google Scholar
• Malik R, Kopylov M, Gomez-Llorente Y, et al. Structure and mechanism of B-family DNA polymerase ζ specialized for translesion DNA synthesis. Nat Struct Mol Biol. 2020;27(10):913–924.
   PubMed Web of Science ®Google Scholar
• Luo H, Chen Z, Wang S, et al. c-Myc–miR-29c–REV3L signalling pathway drives the acquisition of temozolomide resistance in glioblastoma. Brain. 2015;138(12):3654–3672. .
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang S-Y, Wang S, et al. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy. Neuro Oncol. 2009;11(6):790–802. .
   PubMed Web of Science ®Google Scholar
• Roos WP, Tsaalbi-Shtylik A, Tsaryk R, et al. The translesion polymerase Rev3L in the tolerance of alkylating anticancer drugs. Mol Pharmacol. 2009;76(4):927–934.
   PubMed Web of Science ®Google Scholar
• Lu J, Struewing I, Wymer L, et al. Use of qPCR and RT-qPCR for monitoring variations of microcystin producers and as an early warning system to predict toxin production in an Ohio inland lake. Water Res. 2020;170:115262.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhou K, Ma L, et al. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo. Bioengineered. 2020;11(1):219–228.
   PubMed Web of Science ®Google Scholar
• Barrios CE, SantinÓn JJ, Domitrovic HA, et al. Localization and distribution of CCK-8, NPY, Leu-ENK-, and Ghrelin- in the digestive tract of Prochilodus lineatus (Valenciennes, 1836). An Acad Bras Cienc. 2020;92(2):e20181165.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu W, Tao G, et al. Circular RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered. 2020;11(1):932–938.
   PubMed Web of Science ®Google Scholar
• Wu J, Bi A, Zheng F, et al. Wash-free 3D imaging and detection of glioma with a novel neuropotential targeted AIE probe. Chem Commun (Camb). 2021;57(6):801–804.
   PubMed Web of Science ®Google Scholar
• Vassel F-M, Bian K, Walker GC, et al. Rev7 loss alters cisplatin response and increases drug efficacy in chemotherapy-resistant lung cancer. Proc Natl Acad Sci U S A. 2020;117(46):28922–28924.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhu H, Ye W, et al. MicroRNA‑29a enhances cisplatin sensitivity in non‑small cell lung cancer through the regulation of REV3L. Mol Med Rep. 2019;19(2):831–840.
   PubMed Web of Science ®Google Scholar
• Feng L, Wei W, Heng Z, et al. Knockdown of REV7 inhibits breast cancer cell migration and invasion. Oncol Res. 2016;24(5):315–325.
   PubMed Web of Science ®Google Scholar
• Sun X, Hou W, Liu X, et al. Targeting REV7 effectively reverses 5-FU and oxaliplatin resistance in colorectal cancer. Cancer Cell Int. 2020;20(1):580.
   PubMed Web of Science ®Google Scholar
• Yang L, Shi T, Liu F, et al. REV3L, a promising target in regulating the chemosensitivity of cervical cancer cells. PLOS ONE. 2015;10:e0120334.
   PubMed Web of Science ®Google Scholar
• Pang J, Ye L, Zhao D, et al. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer. Cell Biol Int. 2020;44(12):2416–2426.
   PubMed Web of Science ®Google Scholar
• Su P-F, Song S-Q. Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity. Eur Rev Med Pharmacol Sci. 2020;24(22):11461.
   PubMed Web of Science ®Google Scholar
• Elleaume H, Barth RF, Rousseau J, et al. Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma. J Neurooncol. 2020;149:193–208.
   PubMed Web of Science ®Google Scholar
• Liang Z, Xu J, Ma Z, et al. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9. Bioengineered. 2020;11(1):70–80.
   PubMed Web of Science ®Google Scholar
• Wang H, Jiao H, Jiang Z, et al. Propofol inhibits migration and induces apoptosis of pancreatic cancer PANC-1 cells through miR-34a-mediated E-cadherin and LOC285194 signals. Bioengineered. 2020;11(1):510–521.
   PubMed Web of Science ®Google Scholar
• Cao WQ, Zhai XQ, Ma JW, et al. Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway. Pharm Biol. 2020;58:72–79.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhou X, Zhu H, et al. Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT-116. J Biochem Mol Toxicol. 2021;35:e22665.
   PubMed Web of Science ®Google Scholar
• Liu S, Jiang H, Min L, et al. Lysophosphatidic acid mediated PI3K/AKT activation contributed to esophageal squamous cell cancer progression. Carcinogenesis. 2021;42:611–620.
   PubMed Web of Science ®Google Scholar